Azzad Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,035
Closed -$868K 322
2022
Q3
$868K Sell
7,035
-1
-0% -$123 0.09% 292
2022
Q2
$868K Buy
+7,036
New +$868K 0.09% 291
2020
Q3
Sell
-7,030
Closed -$867K 288
2020
Q2
$867K Sell
7,030
-2
-0% -$247 0.2% 166
2020
Q1
$594K Sell
7,032
-7,030
-50% -$594K 0.17% 194
2019
Q4
$1.46M Hold
14,062
0.17% 190
2019
Q3
$1.34M Buy
14,062
+7,036
+100% +$671K 0.17% 198
2019
Q2
$602K Buy
7,026
+481
+7% +$41.2K 0.17% 212
2019
Q1
$581K Buy
6,545
+338
+5% +$30K 0.17% 204
2018
Q4
$529K Hold
6,207
0.18% 204
2018
Q3
$602K Hold
6,207
0.16% 216
2018
Q2
$585K Buy
6,207
+357
+6% +$33.6K 0.17% 210
2018
Q1
$474K Hold
5,850
0.14% 230
2017
Q4
$522K Hold
5,850
0.16% 194
2017
Q3
$544K Hold
5,850
0.18% 189
2017
Q2
$531K Sell
5,850
-2,500
-30% -$227K 0.19% 184
2017
Q1
$733K Hold
8,350
0.28% 148
2016
Q4
$692K Hold
8,350
0.29% 136
2016
Q3
$773K Hold
8,350
0.32% 122
2016
Q2
$650K Hold
8,350
0.28% 137
2016
Q1
$689K Hold
8,350
0.3% 129
2015
Q4
$875K Hold
8,350
0.42% 97
2015
Q3
$879K Sell
8,350
-1,220
-13% -$128K 0.46% 80
2015
Q2
$1.31M Hold
9,570
0.66% 31
2015
Q1
$1.19M Hold
9,570
0.57% 41
2014
Q4
$865K Buy
9,570
+1,469
+18% +$133K 0.46% 75
2014
Q3
$585K Buy
8,101
+1,412
+21% +$102K 0.34% 119
2014
Q2
$416K Sell
6,689
-3,631
-35% -$226K 0.25% 158
2014
Q1
$684K Buy
10,320
+2,265
+28% +$150K 0.45% 82
2013
Q4
$567K Hold
8,055
0.41% 97
2013
Q3
$581K Buy
+8,055
New +$581K 0.48% 73